Abbal Koirala, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Otsuka Pharmaceuticals
    Topic:
    IgA Nephropathy
    Date added:
    06/02/2026
    Date updated:
    06/02/2026
    Relationship end date:
    05/31/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Calliditas Pharmaceuticals
    Topic:
    IgA Nephropathy
    Date added:
    06/02/2026
    Date updated:
    06/02/2026
    Relationship end date:
    08/07/2025
Return to 2026 Inova Fairfax Medicine Grand Rounds: Nephrotic Syndrome